Lyanne Sijbers

Ms. Lyanne Sijbers

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2025 in Cells
Verified
Journal Article
Open access
PDF file
LNLotte Nijhuis
Lotte Nijhuis
ABAlejandra Bodelόn
Alejandra Bodelόn
RSRianne C. Scholman
Rianne C. Scholman
IHIsabelle Houtzager
Isabelle Houtzager
LSLyanne Sijbers
Lyanne Sijbers
JLJorg van Loosdregt
Jorg van Loosdregt
Chronic inflammation and autoimmune diseases are driven, in part, by the activation of (auto)reactive CD4+ T-cells, highlighting their potential as therapeutic targets for these diseases. Nicotinamide (NAM) has demonstrated anti-inflammatory properties in various disease models and has already demonstrated safety in several large clinical trials in humans. The mechanisms behind these observations, and especially their direct effects on CD4+ T-cells, remain poorly understood. Here, we address this gap by investigating how NAM influences CD4+ T-cell activation and function. We also describe that NAM treatment significantly suppresses CD4+ T-cell activation in vitro, as evidenced by impaired proliferation and reduced expression of surface activation markers. Additionally, NAM treatment resulted in reduced production of pro-inflammatory cytokines, IL-2, IFNy, and IL-17, further highlighting its anti-inflammatory potential. We found that NAM modulates key metabolic processes, including glycolysis and reactive oxygen species (ROS) production—both essential to T-cell activation. Taken together, our findings provide novel mechanistic insight into the regulation of T-cell activation by NAM, suggesting NAM as an attractive candidate for novel therapies targeting immune-related diseases.

3 December 2025 in Cells
Verified
Journal Article
Open access
PDF file
MHMaurice J H van Haaren
Maurice J H van Haaren
ABAlejandra Bodelόn
Alejandra Bodelόn
LSLyanne Sijbers
Lyanne Sijbers
RSRianne Scholman
Rianne Scholman
LPLucas Wilhelmus Picavet
Lucas Wilhelmus Picavet
JLJorg van Loosdregt
Jorg van Loosdregt
Alternative splicing is a key regulator of immune regulation by enabling rapid and context-specific responses. However, the role of splicing regulators such as CDC-like kinase 1 (CLK1) in monocyte biology remains poorly defined. Here, we identify and characterize distinct CLK1-splice isoforms in human CD14+ monocytes using long-read RNA sequencing. In resting monocytes, we observe predominant expression of a truncated isoform lacking exon 4 (CLK1Δ4), which undergoes nonsense-mediated decay resulting in minimal protein output. Lipopolysaccharide (LPS) stimulation induces a shift toward the full-length isoform (CLK1+4), associated with increased transcript stability and protein expression. This splicing switch was confirmed by RT-qPCR, short-read RNA sequencing, and Western blot analysis. Pharmacological inhibition of CLK1 selectively reduced TNFα production without affecting cell viability, implicating that the isoform shift enhances pro-inflammatory signaling. These findings uncover a stimulus-dependent splicing mechanism that modulates monocyte activation through differential CLK1 isoform expression and suggest a potential therapeutic avenue by targeting splicing regulators in immune-related disease with an established role of activated monocytes.

29 May 2026 in Nature Communications
Verified
Journal Article
Open access
ABAlejandra Bodelόn
Alejandra Bodelόn
MHMaurice J H van Haaren
Maurice J H van Haaren
PAPaula Sobrevals Alcaraz
Paula Sobrevals Alcaraz
LSLyanne Sijbers
Lyanne Sijbers
RSRianne C. Scholman
Rianne C. Scholman
JLJorg van Loosdregt
Jorg van Loosdregt
Alternative splicing is a key mechanism for expanding transcriptomic and proteomic complexity, yet its role in innate immune activation remains incompletely understood. Here, we applied Oxford Nanopore native RNA-sequencing to generate an isoform-level transcriptome of primary human monocytes before and after activation with lipopolysaccharide. We identify over 24,000 expressed isoforms, including thousands of previously unannotated variants. Activation induced widespread isoform-specific expression changes, leading to extensive isoform switching events, which were validated using matched short-read RNA-Seq. These activation-induced shifts enhanced transcript immune-regulatory functions: activated monocytes preferentially express longer, coding-competent isoforms with complete open reading frames, fewer retained introns, and increased domain complexity. By integrating matched Ribo-seq and proteomic data, we demonstrate that these isoform modulations are associated with enhanced translation of immune effector proteins. Together, our findings position alternative splicing as a dynamic and functional regulator of monocyte activation, emphasizing the need for isoform-level resolution to fully understand immune cell function.

Verified
Journal Article
Open access
PDF file
LPLucas Wilhelmus Picavet
Lucas Wilhelmus Picavet
HAHisham I Abu-Tawil
Hisham I Abu-Tawil
LSLyanne Sijbers
Lyanne Sijbers
JCJorg J. A. Calis
Jorg J. A. Calis
NHNienke ter Haar
Nienke ter Haar
JLJorg van Loosdregt
Jorg van Loosdregt
N6-methyladenosine (m6A) is a dynamic RNA modification that critically modulates gene expression in immune responses. While m6A regulators such as WTAP are implicated in inflammatory and autoimmune diseases, the mechanisms governing their expression during innate immune activation remain unclear. Here, we demonstrate that WTAP expression in human CD14+ monocytes is upregulated upon lipopolysaccharide (LPS) stimulation and is associated with alternative promoter usage leading to distinct mRNA isoforms. Bioinformatic analysis and pharmacological inhibition reveal that the transcription factor RELA (NF-κB pathway) directly contributes to this promoter-specific induction. Functional analyses show that both WTAP isoforms encode identical proteins, indicating transcriptional, rather than post-transcriptional, regulation. These findings uncover a novel NF-κB-dependent mechanism regulating WTAP isoform expression in activated monocytes, providing insight into the epitranscriptomic modulation of inflammation and potential dysregulation in autoimmune disease.